Specification to promote the participation of women in executive positions pursuant to Sections 76 Paragraph 4 and 111 Paragraph 5 of the German Stock Corporation Act (Aktiengesetz - AktG)
Promotion of women in executive positions
An adequate representation of women in the workforce and, in particular, among the executives, provides an important added value to the Biotest Group. In connection with the “German Act on the Equal Participation of Women and Men in Executive Positions in the Private Economy and the Public Service”, Biotest AG set target figures for the participation of women in executive positions, which are to be met by 30 June 2022.
Women on the Supervisory Board
The Supervisory Board of Biotest AG is composed of six members, four of whom represent the shareholders, and two of whom represent the employees. The Supervisory Board is composed of one woman as representative of the shareholders, and one woman as a representative of the employees. By that proportion of 66.6 % of the seats on the Supervisory Board by men and 33.3 % by women, the Company has exceeded the statutory minimum proportion of 30 % women.
Women on the Board of Management
In financial year 2020, no women were represented on the Board of Management. This is in line with the fixed percentage of 0 %, as the Board of Management members in office were appointed for a period beyond 31 December 2020. By 30 June 2022, the proportion of women on the Board of Management is to increase to 25 %.
Women at the first and second management level
The Board of Management of Biotest AG has set a target figure of 20% for the participation of women at the first management level by 30 June 2022 and has already exceeded this target by 31 December 2020 with 21%.. The target figure for the second management level was set at 30 % by 30 June 2022 and as of 31 December 2020, the proportion of women at that management level was 30 %. The proportion of women at Biotest AG (555 female employees) as of 31 December 2020 was 41 %.